You are viewing the site in preview mode

Skip to main content

Table 1 scRNA-seq sample information

From: Single-cell RNA sequencing identifies molecular biomarkers predicting late progression to CDK4/6 inhibition in patients with HR+/HER2- metastatic breast cancer

Timepoint

Sample ID

PFS (months)

Metastatic Site

CDK4/6i

ET agent

Baseline

(n = 8)

PA3

11

Liver

Palbociclib

Fulvestrant

PA5

38

Pleural effusion

Palbociclib

Letrozole

PA45

23

Liver

Palbociclib

Fulvestrant

PA95

12a

Liver

Palbociclib

Letrozole

PA110

31b

Pleural effusion

Palbociclib

Letrozole

PA120

33b

Liver

Palbociclib

Letrozole

PA131

28b

Liver

Abemaciclib

Letrozole

PA153

18

Liver

Palbociclib

Letrozole

Early Progressor

(n = 3)

PA46

5

Pleural effusion

Palbociclib

Fulvestrant

PA11

3

Pleural effusion

Palbociclib

Fulvestrant

PA144

3

Liver

Palbociclib

Fulvestrant

Late Progressor

(n = 7)

PA1

13

Pleural effusion

Palbociclib

Fulvestrant

PA3 #1

11

Ascites

Palbociclib

Fulvestrant

PA3 #2

11

Ascites

Palbociclib

Fulvestrant

PA126

9

Liver

Palbociclib

ZN-c5

PA139

8

Liver

Palbociclib

Letrozole

PA99

9

Pleural effusion

Palbociclib

Anastrozole

PA165

37

Pelvic bone

Palbociclib

Anastrozole

  1. alost to follow-up
  2. bstill under treatment